Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement

American Journal of Surgical Pathology

Volumn 20, Issue SUPPL. 1, 1996, Pages

  Solcia, Enrico ^a,b   Fiocca, Roberto ^a   Luinetti, Ombretta ^a   Villani, Laura ^a   Padovan, Laura ^b   Calistri, Daniele ^b   Ranzani, Guglielmina N ^b   Chiaravalli, Annamaria ^b   Capella, Carlo ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Carcinogenesis; Chronic gastritis; Dysplasia; Gastric cancer; Helicobacter pylori; Intestinal metaplasia types; p53 gene mutations; p53 protein expression; Tumor cell phenotype

Indexed keywords

INTEGRIN; LAMININ; PROTEIN P53;

ARTICLE; ATROPHIC GASTRITIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CARCINOGENESIS; CHRONIC GASTRITIS; DYSPLASIA; EXTRACELLULAR MATRIX; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE CANCER; INTESTINE METAPLASIA; PHENOTYPE; STOMACH CANCER; STOMACH GLAND; STOMACH MUCOSA;

EID: 0029791480     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199600001-00003     Document Type: Article

References (63)

1. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-52.
2. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327:293-7.
3. Chen XG, Correa P, Offerhaus J, et al. Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol 1986;86:575-82.
4. Cho C, Murthy UK, Linscheer WG, Perez-Perez GI, Blaser MJ. Is intestinal metaplasia a consequence of H. pylori gastritis? [Abstract]. Gastroenterology 1994;106:A62.
5. Chong JM, Fukayama M, Hayashi Y, et al. Microsatellite instability in the progression of gastric carcinoma. Cancer Res 1994;54:4595-7.
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
7. Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia in the stomach of Colombian migrants. J Natl Cancer Inst 1970;44:297-306.
8. Correa P, Ruiz P. Campylobacter pylori and gastric cancer. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell, 1989: 139-45.
9. Eckardt VF, Willems D, Kanzler G, Remmele W, Bettendorf U, Paulus W. Eighty months persistence of poorly differentiated early gastric. Gastroenterology 1984;87:719-24.
10. Fertitta AM, Comin U, Terruzzi V, et al. Clinical significance of gastric dysplasia: a multicenter follow-up study. Endoscopy 1993;25:265-8.
11. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
12. Fiocca R, Cornaggia M, Villani L, Capella C, Solcia E, Samloff M. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases. Cancer 1988;61:956-62.
13. Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol 1994;29(suppl 205):11-21.
14. Fiocca R, Liunetti O, Villani L, et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993;5(suppl 2):S2-8.
15. Fiocca R, Villani L, Luinetti O, et al. Helicobacter colonization and histopathologic profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer. A morphologic approach to the study of ulcerogenesis in man. Virchows Arch [A] 1992;420:489-98.
16. Fiocca R, Villani L, Tenti P, et al. Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumors. Pathol Res Pract 1987;182:308-25.
17. Fiocca R, Villani L, Tenti P, et al. Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody. J Clin Pathol 1988;41:178-87.
18. Fiocca R, Villani L, Tenti P, et al. The foveolar cell component of gastric cancer. Hum Pathol 1990;21:260-70.
19. Forman D and the Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
20. Goldman H, Ming SC. Fine structure of intestinal metaplasia and adenocarcinoma of the human stomach. Lab Invest 1968;18:203-10.
21. Grabiec J, Owen DA. Carcinoma of the stomach in young persons. Cancer 1985;56:388-96.
22. Hawksworth GM, Hill MJ. Bacteria and N-nitrosation of secondary amines. Br J Cancer 1971;25:520-6.
23. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancer. Science 1991;253:49-53.
24. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981;29:577-80.
25. Ishii S, Steele G Jr, Ford R, et al. Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology 1994;106:1242-50.
26. Johansen A. Early gastric cancer. A contribution to the pathology and to gastric cancer histogenesis. Copenhagen: Bisperbjerg Hospital, 1981.
27. Karnes WE Jr, Samloff IM, Siurala M, et al. Positive serum antibodies and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
28. Kihana T, Tsuda H, Hirota T, et al. Point mutation of C-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 1991;82:308-14.
29. Kodama Y, Inokuchi K, Soejima K, Matsusaka T, Okamura O. Growth patterns and prognosis in early gastric carcinoma. Cancer 1983;51:320-6.
30. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
31. Matsui S, Shiozaki H, Inoue M, et al. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch 1994;424:375-81.
32. Matsusaka T, Kodama Y, Soejima K, et al. Recurrence in early gastric cancer: a pathologic evaluation. Cancer 1980; 46:168-78.
33. Nagayo T. Microscopical cancer of the stomach: a study on histogenesis of gastric carcinoma. Int J Cancer 1975;16: 52-60.
34. Nakatsuru S, Yanagisawa A, Furukawa Y, et al. Somatic mutations of the APC gene in precancerous lesions of the stomach. Hum Mol Genet 1993;2:1463-5.
35. Nakatsuru S, Yanagisawa A, Ichii S, et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992;1:558-63.
36. Nguyen T, Brunson D, Crespi CL, Penmaan BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030-4.
37. Parsonnet J, Friedman GF, Vandersteen D, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
38. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54:1556-60.
39. Prat M, Medico E, Garrino C, Comoglio PM. Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. Int J Cancer 1989;44:67-74.
40. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
41. Ranzani GN, Luinetti O, Padovan LS, et al. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 1995;4:223-31.
42. Ranzani GN, Renault B, Pelegata NS, et al. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet 1993;92:244-9.
43. Renault B, Van Den Broek M, Fodde R, et al. Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 1993;53:2614-7.
44. Rideout WM, Coetzee GA, Olumi AF, Jones PA. 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-90.
45. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32:1110-3.
46. Rugge M, DiMario F, Cassaro M, et al. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology 1993;22: 9-15.
47. Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Gastroenterology 1994;107: 1288-96.
48. Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991;51:2185-92.
49. Silva S, Filipe MI. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects. A comparative analysis of biopsy and gastrectomy material. Hum Pathol 1986;17:988-95.
50. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35: 173-7.
51. Sipponen P, Riihela M, Hyvarinen H, Seppala K. Chronic nonatrophic ('superficial') gastritis increases the risk of gastric carcinoma: a case-control study. Scand J Gastroenterol 1994;29:336-40.
52. Sockett H, Romac S, Hutchinson F. Mutagenic specificity of N-methyl-N′-nitro-N nitrosoguanidine in the gpt gene on a chromosome of Chinese hamster ovary cells and of Escherichia coli cells. Mol Gen Genet 1991;227:252-9.
53. Solcia E, Fiocca R, Villani L, et al. The role of Helicobacter pylori gastritis in ulcerogenesis and cancerogenesis. In: Gasbarrini G, Pretolani S, eds. Basic and clinical aspects of H. pylori infection. Berlin: Springer-Verlag, 1994:101-12.
54. Solcia E, Villani R, Fiocca R, et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994;29(suppl 201):28-34.
55. Strickler JG, Zheng J, Shu Q, Burgart LJ, Alberts SR, Shibata D. p53 mutations and microsatellite instability on sporadic gastric cancer: when guardians fail. Cancer Res 1994; 54:4750-5.
56. Stuehr DJ, Marietta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 1987;47:5590-4.
57. Tahara E. Molecular mechanism of stomach cancerogenesis. J Cancer Res Clin Oncol 1993;119:265-72.
58. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
59. Torrado J, Correa P, Rutz B, Bernardi P, Zavala D, Bara J. Lewis antigen alterations in gastric cancer precursor. Gastroenterology 1992;102:424-30.
60. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
61. Uchino S, Tsuda H, Noguchi M, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 1992;52:3099-102.
62. Watanabe H, Kamikawa M, Nakagawa Y, Takahashi I, Ito A. The effects of ranitidine and cysteamine on intestinal metaplasia induced by x-irradiation in rats. Acta Pathol Jpn 1988;38:1285-96.
63. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-3.